About FUJIFILM Cellular Dynamics
FUJIFILM Cellular Dynamics is a Healthcare company based in Madison (United States) founded in 2004. It operates as a provider of induced pluripotent stem cells for cell therapy. FUJIFILM Cellular Dynamics has raised $61.67 million across 4 funding rounds from investors including National Science Foundation. Its chief executive is Takeshi Yamamoto. Its website fujifilmcdi.com draws about 13 thousand monthly visits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its competitors include Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio and 5 more; 8 of its 10 listed competitors have raised funding.
Company details
Fujifilm Cellular Dynamics is a provider of induced pluripotent cells for cell therapy. The company has developed techniques for developing and manufacturing induced pluripotent stem (iPS) cells and differentiating them into functional human cells. The company provides induced pluripotent cardiac cells, neural cells, hematopoietic cells and reagents.
- Headquarters Madison, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website fujifilmcdi.com
- Social LinkedIn X Facebook
- Total Equity Funding$61.67M (USD)
in 4 rounds
- Latest Funding Round$21.04M (USD), Series C
Nov 2012
- Investors
Funding Insights of FUJIFILM Cellular Dynamics
FUJIFILM Cellular Dynamics has successfully raised a total of $61.67M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $21.04 million completed in November 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $61.67M
- Total Rounds 4
- Last Round Series C — $21.04M
- First Round $616,000
(Jul 2008)
- Investors Count 1
All 4 funding rounds of FUJIFILM Cellular Dynamics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2012 | $21.04M | Series C | – | – | – |
| Feb 2010 | $40.63M | Series C | – | – | – |
| Oct 2008 | $616,000 | Grant | – | – | |
| Jul 2008 | $616,000 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in FUJIFILM Cellular Dynamics
FUJIFILM Cellular Dynamics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for FUJIFILM Cellular Dynamics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of FUJIFILM Cellular Dynamics
104 people are tracked at FUJIFILM Cellular Dynamics (25 in leadership, 79 in team).
| Name | Role | Group |
|---|---|---|
Takeshi Yamamoto | Chairman & CEO | Leadership |
Kazuyoshi Hirao | Chairman & CEO | Leadership |
Brian Riley | Associate Director | Leadership |
Chris McMahon | Senior Director Of Parkinson's And Immune Cell Therapy | Leadership |
Lucas Chase | Executive Director, Therapeutics R&d | Leadership |
Chad Koonce | Senior Director - Ipsc Platform | Leadership |
Virginia Mattis | Director Of Neurotherapeutics | Leadership |
Steve Fischer | Director, Process & Analytical Development | Leadership |
Gregory Wiegand | Associate Director Quality Control | Leadership |
Andrew Dias | R&d Associate Director, Therapeutics | Leadership |
Sonsy Pulikotil Rajan | Head of Intellectual Property Affairs | Leadership |
Peter Fuhrken | Vice President of Technical Operations | Leadership |
Tomoyuki Hasegawa | President and CEO | Leadership |
Marie Uphoff | Director of Project & Portfolio Management | Leadership |
Takashi Okada | Chief Technology Officer | Leadership |
Coby Carlson | Director, Innovation and New Technology | Leadership |
Leonardo Salado | Head Of Information Technology | Leadership |
Blake Anson | Senior Director - Discovery Research Partnering | Leadership |
Eugenia (Genie) Jones | Vice President External Development and Partnering | Leadership |
Yina P Santiago-Rodriguez | R&d Associate Director | Leadership |
84 more people are available in the full profile.
Complete people profiles for FUJIFILM Cellular Dynamics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of FUJIFILM Cellular Dynamics
3 dated milestones of FUJIFILM Cellular Dynamics across 8 years, from founding to its latest funding, stage changes and deals.
- Founded FUJIFILM Cellular Dynamics is founded.
- Funding First funding round of $616K.
- Funding Latest funding round, Series C, of $21.0M.
Competitors of FUJIFILM Cellular Dynamics
FUJIFILM Cellular Dynamics has 10 listed competitors in our database, 8 of them funded. They include Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| straumann.com | 1954 | Basel, Switzerland | – | – | Dental implants and regenerative dentistry products are developed. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| judges.uk.com | 2002 | London, United Kingdom | – | 622 | Acquisition and development of scientific instrument businesses is conducted. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. |
Detailed competitors of FUJIFILM Cellular Dynamics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of FUJIFILM Cellular Dynamics
The website of FUJIFILM Cellular Dynamics (fujifilmcdi.com) receives about 13K visits a month.
- Monthly visits13K
▼ 2.3% vs previous month
Websites whose visitors overlap most with FUJIFILM Cellular Dynamics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| axolbio.com | 100% | 13.6K | #1,907,884 | View details | |
| axionbiosystems.com | 97% | 35.5K | #817,660 | View details | |
| criver.com | 95% | 224.6K | #186,811 | View details | |
| novateinbio.com | 94% | – | #2,211,246 | View details | |
| ixcellsbiotech.com | 88% | 14.2K | #1,627,815 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for FUJIFILM Cellular Dynamics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as FUJIFILM Cellular Dynamics (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Fujifilm Cellular Dynamics
Complete news archive for FUJIFILM Cellular Dynamics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FUJIFILM Cellular Dynamics
FUJIFILM Cellular Dynamics was founded in 2004 and raised its 1st funding round 4 years after it was founded.
FUJIFILM Cellular Dynamics is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
Takeshi Yamamoto is the current CEO of FUJIFILM Cellular Dynamics.
FUJIFILM Cellular Dynamics is a funded company, having raised a total of $61.67M across 4 funding rounds to date. The company's 1st funding round was a Grant of $616K, raised on Jul 2008.
Fujifilm Cellular Dynamics is a provider of induced pluripotent cells for cell therapy. The company has developed techniques for developing and manufacturing induced pluripotent stem (iPS) cells and differentiating them into functional human cells. The company provides induced pluripotent cardiac cells, neural cells, hematopoietic cells and reagents.
FUJIFILM Cellular Dynamics's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
FUJIFILM Cellular Dynamics has 1 investor. Key investors include National Science Foundation.